Masimo (MASI)
(Delayed Data from NSDQ)
$125.46 USD
+0.66 (0.53%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $125.53 +0.07 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Masimo Corporation [MASI]
Reports for Purchase
Showing records 281 - 300 ( 484 total )
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
1Q15 Preview: Trends Look Better Than Initially Expected
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Takeaways from J-J''s 1Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare -1Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Greater Confidence in EPS Leverage Story; Raising PT to $36 and Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Q4 results ahead of expectations, guidance below consensus on FX
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
Currency Drags Down 2015 Guidance but Inline Underlying Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
Solid 4Q Driven by Utilization and Margin Improvements, But FX Weighs on FY15 Outlook; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
4Q14 Preview: Expecting Positive Trends in Core Pulse Ox Business to Continue; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
4Q14 Preview - Cautious on 2015 Reported Outlook Due to Fx Headwinds
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
Elevated Flu Season Remains a Tailwind for MASI; Influenza-related Hospitalizations for Elderly at 9-Year High
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Elevated Flu Season Remains a Tailwind for Influenza-related Hospitalizations for Elderly at 9-Year High
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
4Q Preview: Positive Pre-Announcements Bode Well for 2015
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Healthcare: 4Q 2014: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C